🔗 Visit the ClinicalTrials.gov page for NCT00992186
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Macrophages and therapeutic resistance in cancer. | Cancer Cell | 2015 | 1.95 |
| 2 | Drug resistance in metastatic castration-resistant prostate cancer. | Nat Rev Clin Oncol | 2010 | 1.86 |
| 3 | Combination cancer immunotherapies tailored to the tumour microenvironment. | Nat Rev Clin Oncol | 2015 | 1.54 |
| 4 | Tumor cells and tumor-associated macrophages: secreted proteins as potential targets for therapy. | Clin Dev Immunol | 2011 | 1.41 |
| 5 | Anti-tumour strategies aiming to target tumour-associated macrophages. | Immunology | 2013 | 1.40 |
| 6 | Overcoming drug resistance and treating advanced prostate cancer. | Curr Drug Targets | 2012 | 0.95 |
| 7 | Bone marrow fat: linking adipocyte-induced inflammation with skeletal metastases. | Cancer Metastasis Rev | 2014 | 0.92 |
| 8 | PPM1A is a RelA phosphatase with tumor suppressor-like activity. | Oncogene | 2013 | 0.88 |